...
首页> 外文期刊>Bulletin of experimental biology and medicine >Efficiency and Tolerance of Aranose Combinations with Cisplatin and Gemcitabine in Experimental Lung Cancer
【24h】

Efficiency and Tolerance of Aranose Combinations with Cisplatin and Gemcitabine in Experimental Lung Cancer

机译:阿糖与顺铂和吉西他滨联用在实验性肺癌中的有效性和耐受性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The efficiency of aranose combinations with gemcitabine and cisplatin was studied in experimental Lewis lung epidermoid carcinoma. Significant synergism of all the studied combinations and their satisfactory tolerance was demonstrated. The gemcitabine+cisplatin+aranose combination was significantly more effective than gemcitabine+cisplatin.The search for new drug combinations is one of approaches to improving the efficiency of chemotherapy of small-cell and non-small-cell lung cancer. Effective drugs for lung cancer are platinum compounds, gemcitabine (G), and nitrosourea derivatives. The efficiency of gemcitabine+cisplatin (GP) combination characterized by a synergistic effect was demonstrated for experimental lung cancer [5,6].
机译:在实验性刘易斯肺表皮样癌中研究了吉西他滨和顺铂组合阿糖的效率。证明了所有研究组合的显着协同作用和令人满意的耐受性。吉西他滨+顺铂+阿诺糖联合治疗比吉西他滨+顺铂联合治疗明显更有效。寻找新药组合是提高小细胞和非小细胞肺癌化疗效率的途径之一。对肺癌有效的药物是铂化合物,吉西他滨(G)和亚硝基脲衍生物。吉西他滨+顺铂(GP)组合具有协同效应的功效已被证明可用于实验性肺癌[5,6]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号